Latest News & Features
Americas
The system governing preliminary injunctions for pharmaceutical patent infringement should be revised to
stave off potential frivolous cases, say Hedwig Lindner and Manuel Morante. 1 May 2012
Americas
When introducing medicinal products to any market, the strength of the trademark is crucial. But the Mexican system requires getting trademark approval from two different authorities. 1 May 2012
Big Pharma
Brazil’s IP system has struggled to keep pace with its economic growth, but as Otto Licks and Marcela Trigo explain, there are some promising signs. 1 May 2012
Asia
For the first time in the history of the Indian patent system, a compulsory licence has been granted. Archana Shanker considers the implications. 1 May 2012
article
LSIPR talks to Matt McBride about how Science IP can help businesses ensure their patent plans get off to the best possible start. 1 May 2012
Big Pharma
Russia’s life sciences industry is growing rapidly, say Vadim Chagin and Maria Nilova. 1 May 2012
Biotechnology
The Supreme Court’s much-anticipated Prometheus decision has prompted strong reactions among IP practitioners, as MaryAnne Armstrong, PhD, explains. 1 January 2012
Big Pharma
When it comes to life sciences, Boston is out on its own. LSIPR takes a look at innovation in the Olde Towne. 1 January 2012
Biotechnology
For the Biotechnology Industry Organization, key developing markets pose particular challenges in terms of
IP and also in a wider context. LSIPR spoke to Joe Damond and Lila Feisee about international affairs. 1 January 2012
Biotechnology
The patentability of biotech inventions should meet substantive requirements such as novelty, inventive step and industrial applicability, but EPO developments suggest that formalities are increasingly important. 1 January 2012